4.6 Article

Prediction of Radiation Pneumonitis Using Genome-Scale Flux Analysis of RNA-Seq Derived From Peripheral Blood

期刊

FRONTIERS IN MEDICINE
卷 8, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2021.715961

关键词

radiation pneumonitis; prediction model; peripheral blood; RNA-Seq; chest radiotherapy; risk prediction; transcriptome analysis

资金

  1. Wu Jie-ping Medical Foundation [320.6750.19094-18]

向作者/读者索取更多资源

This study developed an RP scoring system using RNA sequencing data and genome-scale flux analysis to accurately predict the occurrence of RP before radiotherapy. The results indicated significant associations between radiation dose and RP, and the RP scoring system showed high consistency with clinically observed outcomes.
Purpose: Radiation pneumonitis (RP) frequently occurs during a treatment course of chest radiotherapy, which significantly reduces the clinical outcome and efficacy of radiotherapy. The ability to easily predict RP before radiotherapy would allow this disease to be avoided. Methods and Materials: This study recruited 48 lung cancer patients requiring chest radiotherapy. For each participant, RNA sequencing (RNA-Seq) was performed on a peripheral blood sample before radiotherapy. The RNA-Seq data was then integrated into a genome-scale flux analysis to develop an RP scoring system for predicting the probability of occurrence of RP. Meanwhile, the clinical information and radiation dosimetric parameters of this cohort were collected for analysis of any statistical associations between these parameters and RP. A non-parametric rank sum test showed no significant difference between the predicted results from the RP score system and the clinically observed occurrence of RP in this cohort. Results: The results of the univariant analysis suggested that the tumor stage, exposure dose, and bilateral lung dose of V5 and V20 were significantly associated with the occurrence of RP. The results of the multivariant analysis suggested that the exposure doses of V5 and V20 were independent risk factors associated with RP and a level of RP >= 2, respectively. Thus, our results indicate that our RP scoring system could be applied to accurately predict the risk of RP before radiotherapy because the scores were highly consistent with the clinically observed occurrence of RP. Conclusion: Compared with the standard statistical methods, this genome-scale flux-based scoring system is more accurate, straightforward, and economical, and could therefore be of great significance when making clinical decisions for chest radiotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

BACH1: A Potential Predictor of Survival in Early-Stage Lung Adenocarcinoma

Jin Zhou, Zheming Liu, Huibo Zhang, Tianyu Lei, Jiahui Liu, Yaqi Zhao, Yi Yao, Qibin Song

Summary: This study explores the value of BACH1 in predicting the overall survival of early-stage lung adenocarcinoma. It establishes a BACH1 expression-based prognostic model that shows good predictive power and clinical applicability. Higher expression of BACH1 is associated with worse overall survival in patients with lung adenocarcinoma.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Oncology

Increased Drp1 promotes autophagy and ESCC progression by mtDNA stress mediated cGAS-STING pathway

Yujia Li, Hui Chen, Qi Yang, Lixin Wan, Jing Zhao, Yuanyuan Wu, Jiaxin Wang, Yating Yang, Menglan Niu, Hongliang Liu, Junqi Liu, Hushan Yang, Shaogui Wan, Yanming Wang, Dengke Bao

Summary: Our study reveals that Drp1 overexpression induces mitochondrial dysfunction and cytosolic mtDNA stress, thereby activating the cGAS-STING pathway, promoting autophagy, and enhancing ESCC progression. The findings suggest a potential mechanism for targeting Drp1 in cancer therapy.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Biochemical Research Methods

Generation of Allogeneic CAR T Cells through Specific Degradation of the T Cell Antigen Receptor by E3 Ubiquitin Ligase Fusion Proteins

Michael J. Harris, Hao Chen, Tianyu Cai, Yuting Yi, Qaowen Deng, Yi Yao, Tianle Lan, Yanfeng Guo, Xiufang Xu, Xian Wen, Joshua E. McGee, Daniella Tatang, James Brock, Feng Shi, Li Zhou

Summary: The study demonstrates a synthetic E3 fusion protein called ReceptorTAC, which can regulate gene expression by targeting T cell antigen receptor degradation, achieving specific degradation of TCR.

ACS SYNTHETIC BIOLOGY (2022)

Article Oncology

Tumor-Educated Platelets Facilitate Thrombus Formation Through Migration

Zheming Liu, Jing Wang, Fuben Liao, Qibin Song, Yi Yao

Summary: Platelets are small anucleate cells that circulate in the blood and form thrombi. Tumor-educated platelets derived from cancer patients play a role in cancer-associated thrombosis. Studies show that tumor-educated platelets from melanoma-burdened mouse models demonstrate enhanced migration and clot formation, but are inhibited by plasma from tumor mice. RNA sequence profile of tumor-educated platelets reveals upregulation of genes associated with cell migration and cytoskeleton, shedding light on the process of thrombus formation.

FRONTIERS IN ONCOLOGY (2022)

Article Immunology

Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma

Haohan Zhang, Yi Yao, Jie Wu, Jin Zhou, Chen Zhao, Junju He, Bin Xu

Summary: By analyzing the scores and clustering of various cells in the tumor microenvironment of hepatocellular carcinoma, this study identified four subtypes with different biological characteristics and potential relevance.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

SEER-Based Survival Nomogram (1998-2015) Based on 'Stage, Lymph Node Dissection, Tumor Size and Degree of Differentiation, and Therapies' for Prognosis of Primary Pulmonary Sarcoma

Hao Gu, Ruixia Song, Narasimha M. Beeraka, Tingxuan Li, Di Zhao, Junqi Liu, Ruitai Fan

Summary: The objective of this study was to construct a nomogram for predicting the overall survival (OS) of patients with primary pulmonary sarcoma (PPS). The nomogram was based on stage, lymph node dissection, tumor size, degree of differentiation, and therapies. The nomogram showed a strong predictive ability with high accuracy for the prognosis of PPS patients.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2023)

Article Oncology

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment

Songjiang He, Shi Zhang, Yi Yao, Bin Xu, Zhili Niu, Fuben Liao, Jie Wu, Qibin Song, Minglun Li, Zheming Liu

Summary: Glutamine metabolism is significant in the clinical outcomes of patients with pan-cancer and is closely associated with several hallmarks of a malignant tumor.

FRONTIERS IN ONCOLOGY (2022)

Article Pharmacology & Pharmacy

FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis

Yingge Li, Jie Chen, Bin Wang, Ziwen Xu, Ci Wu, Junfeng Ma, Qibin Song, Qing Geng, Jinming Yu, Huadong Pei, Yi Yao

Summary: This study aims to investigate the regulatory mechanisms of nucleotide de novo synthesis and drug resistance. By analyzing ChIP-Seq data, RNA sequencing, and luciferase-based promoter assay, the researchers identified FOXK2 as a key regulator of nucleotide de novo synthesis. FOXK2 directly regulates the expression of nucleotide synthetic genes, promoting tumor growth and cancer cell resistance to chemotherapy. In clinical analysis, elevated expression of FOXK2 is associated with increased nucleotide synthetic gene expression and poor prognosis in hepatocellular carcinoma patients.

DRUG RESISTANCE UPDATES (2023)

Article Oncology

High Body Mass Index Was Associated With Human Epidermal Growth Factor Receptor 2-Positivity, Histological Grade and Disease Progression Differently by Age

Di Zhao, Xiaoyan Wang, Narasimha M. Beeraka, Runze Zhou, Haohao Zhang, Yanxia Liu, Yinghui Zhang, Ying Zhang, Guijun Qin, Junqi Liu

Summary: This study aimed to elucidate the association between high body mass index (BMI) and pathological findings in breast cancer patients. The results showed that for women under the age of 55, high BMI was associated with lower breast cancer incidence (OR = 0.313, CI: 0.240 -0.407), while in women over the age of 55, it was associated with histological grade lower than 2 (OR = 0.288, CI: 0.152 -0.544).

WORLD JOURNAL OF ONCOLOGY (2023)

Article Chemistry, Multidisciplinary

Accurate and Convenient Lung Cancer Diagnosis through Detection of Extracellular Vesicle Membrane Proteins via Forster Resonance Energy Transfer

Shuting Xiao, Yi Yao, Shuilin Liao, Bin Xu, Xue Li, Yuxiao Zhang, Lei Zhang, Qiang Chen, Haoneng Tang, Qibin Song, Ming Dong

Summary: Researchers have developed an EV-MPDS system based on FRET signals, which allows convenient diagnosis of lung cancer without the need for EV extraction and purification. In clinical samples, this system demonstrated improved accuracy and sensitivity compared to the ELISA detection method, with early screening accuracy further enhanced through machine learning analysis of five biomarkers.

NANO LETTERS (2023)

Article Oncology

Regulation of ferroptosis-related genes in CD8+NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer

Zheming Liu, Songjiang He, Zhou Huang, Jiahui Liu, Yiping Gong, Yi Yao, Xue Zhang

Summary: Drug resistance is a major challenge in immunotherapy for triple negative breast cancer patients. This study investigated the mechanisms of drug resistance using single-cell RNA sequencing data and TCGA transcriptomic data. CD8+ NKT cells and classical monocytes were found to play vital roles in the immunotherapy response, and DUSP1 was identified as a potential key factor in immunotherapy resistance.

THORACIC CANCER (2023)

Review Oncology

Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review

Yingmei Wen, Yi Dong, Lina Yi, Guifang Yang, Mengxia Xiao, Qingqing Li, Chen Zhao, Dafu Ye, Yi Yao

Summary: This study reports the treatment course of a patient with advanced pulmonary sarcomatoid carcinoma. The patient initially received treatment with anlotinib, followed by the addition of Pembrolizumab, leading to partial response. The patient survived for 14 months with no significant adverse reactions during treatment. Genomic analysis revealed mutations associated with treatment efficacy.

FRONTIERS IN ONCOLOGY (2023)

Review Biochemistry & Molecular Biology

De novo nucleotide biosynthetic pathway and cancer

Jie Chen, Siqi Yang, Yingge Li, Xu Ziwen, Pingfeng Zhang, Qibin Song, Yi Yao, Huadong Pei

Summary: The de novo nucleotide biosynthetic pathway is a highly conserved and crucial biochemical pathway found in almost all organisms. Dysregulation of this pathway has been linked to the development of many human diseases, including cancer. In this review, the authors provide a comprehensive overview of the pathway, its regulatory mechanisms, its role in tumorigenesis, and potential targeting opportunities.

GENES & DISEASES (2023)

Meeting Abstract Oncology

Comparative efficacy and safety of immunotherapy for advanced NSCLC: A systematic review and network meta-analysis.

Bin Xu, Chen Zhao, Hao Zhong, Tianyu Lei, Huibo Zhang, Jie Wu, Lan Li, Yi Yao, Qibin Song

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Identification and validation for biological characteristics and prognosis of tumor microenvironment subtypes in patients with lung adenocarcinoma.

Yi Yao, Jin Zhou, Haohan Zhang, Jie Wu, Yaqi Zhao, Zheming Liu, Bin Xu, Qibin Song

JOURNAL OF CLINICAL ONCOLOGY (2022)

暂无数据